Bayer Hit with Birth Control Lawsuit from 5 Blood Clot Victims

Five women are suing Bayer Healthcare Pharmaceuticals Inc. after suffering injuries from their birth control pills. Each woman alleges in the joint Yaz lawsuit that they suffered blood clot injuries in direct consequence of taking Yaz and Yasmin oral contraceptives.

The group of plaintiffs in the Yaz lawsuit are awaiting litigation proceedings along with thousands of other women involved birth control lawsuits against Bayer.  The case, which is similar to a Yaz class action lawsuit, is brought on behalf of the following women, which hail from California and Georgia:

• Whitney Banks began taking Yaz in January 2008 until May 2008.  She ended the medication because she had been diagnosed with deep vein thrombosis, and had not been warned of it being a possible side effect, the Yaz lawsuit alleges.
• Kelly Bowman used Yaz from May 2007 through Nov. 14, 2009, when she was diagnosed with bilateral deep vein thrombosis. She is suing Bayer Pharmaceuticals for not warning her that her injury had been a possible side effect.
• Theresa Crew took Yaz beginning in October 2008 until July 21, 2011 because she was diagnosed with deep vein thrombosis and was told that the oral contraceptive was the cause. She is also suing Bayer for not warning her that blood clots were a possible side effect.
• Megan Evans, the only plaintiff from Georgia, started using Yasmin in 2006 until March 2007. She stopped the medication after she was diagnosed with deep vein thrombosis. At the time of her injury diagnosis, she had been a resident in California, and like the other women, she is suing Bayer for not properly labeling Yaz and Yasmin’s side effects.
• Brittany Garrett was first been prescribed Yasmin in January 2005, but stopped taking the oral contraceptive on  June 21, 2005, after she was diagnosed with bilateral pulmonary emboli.  Garret is suing Bayer Pharmaceuticals for the injuries she suffered from their birth control pill, stating in her Yasmin class action lawsuit that her injury was not listed as a side effect.

Each of these women are now living with the daily complications of their blood clot injuries, and each must undergo regular checkups and follow a strict diet as a result of their birth control blood clots, the Yaz lawsuit claims. All plaintiffs state in their Yaz and Yasmin lawsuit that Bayer had the responsibly to warn them and other patients of these and other possible side effects, because they were relying on the accuracy of the given information. Each plaintiff contends that they would not have taken the birth control pills if they had known about these risks.

The plaintiffs’ charges against Bayer include negligence, false advertising, concealing information, and misrepresenting a product.

 Overview of Yaz and Yasmin Complications

Yaz and Yasmin are two very popular oral contraceptives which are manufactured by that were approved by the U.S. Food and Drug Administration (FDA) in 2006 and 2001 respectively. Both birth control pills are combination oral contraceptives (COCs), where the pills contain both a progestin and estrogen component.  The progestin component in particular, drospirenone, is what makes Yaz and Yasmin stand out compared to other birth control pills. Drospirenone is a fourth-generation progestin, only developed recently and is only used for Bayer’s brand name drugs.

While Bayer had originally boasted of this fact, due to recent Yaz and Yasmin lawsuits and injury reports, Bayer no longer advertises drospirenone as heavily.

Medical experts ay that very little is known about how drospirenone effects the body, and that Bayer should not have used it without sufficient pre-clinical testing. Drospirenone is a known diuretic, which means it slows the blood down with high potassium levels, which allows for the formation of blood-clots.

Yaz Lawsuit v. Yaz Class Action Lawsuit

Yaz and Yasmin class action lawsuits are being filed by patients who have suffered from blood clotting injuries.

A class action lawsuit is a group lawsuit for those who have similar injuries from the same product and believe they are owed similar compensation. All class members in a class action lawsuit will share equally in the settlement, but there is a cap on how much each class member will receive. In an individual Yaz lawsuit, there is no cap on much a person will receive.

Yaz and Yasmin individual lawsuits have been consolidated into a single multidistrict litigation (MDL), which is very similar to a class action lawsuit. In an MDL, also called a Mass Tort, is several individual lawsuits are organized together under a single judge at the same court. This is often more appropriate for defective drugs or medical devices because the injuries can vary. However, an MDL allows plaintiffs to use one attorney or a group of attorneys to represent them, and all lawsuits are able to use any information garnered through the discovery process making it more efficient for all attorneys involved representing both the plaintiffs and the defendants.

The women’s case will join thousands of others filed in the Yaz Mass Tort, which is In Re: Yasmin and Yaz (Drospirenone) Products Marketing, Sales Practices And Relevant Liability Litigation, MDL No. 2100, in the U.S. District Court of Southern Illinois.

File a Yaz and Yasmin Class Action Lawsuit Claim

If you believe that you or a loved one have been the victim of a Yaz blood clot injury, legal options are available.  For more information please visit the Birth Control Lawsuits: Yaz, Yasmin, Beyaz, Gianvi, Ocella Class Action Lawsuit Investigation. There, you can submit your claim for a free legal review, and if it qualifies for legal action, a seasoned Yaz lawyer will contact you for a free, no-obligation consultation.  You will be guided through the litigation process at no out-of-pocket expenses or hidden fees.  The blood clot attorneys working this investigation do not get paid until you do.